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Abstract
Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that specifically affects motor neurons and
leads to a progressive and ultimately fatal loss of function, resulting in death typically within 3 to 5 years of diagnosis. The
disease starts with a focal centre of weakness, such as one limb, and appears to spread to other parts of the body. Mutations
in superoxide dismutase 1 (SOD1) are known to cause disease and it is generally accepted they lead to pathology not by
loss of enzymatic activity but by gain of some unknown toxic function(s). Although different mutations lead to varying
tendencies of SOD1 to aggregate, we suggest abnormal proteins share a common misfolding pathway that leads to the
formation of amyloid fibrils.
Methodology/Principal Findings: Here we demonstrate that misfolding of superoxide dismutase 1 leads to the formation
of amyloid fibrils associated with seeding activity, which can accelerate the formation of new fibrils in an autocatalytic
cascade. The time limiting event is nucleation to form a stable protein ‘‘seed’’ before a rapid linear polymerisation results in
amyloid fibrils analogous to other protein misfolding disorders. This phenomenon was not confined to fibrils of
recombinant protein as here we show, for the first time, that spinal cord homogenates obtained from a transgenic mouse
model that overexpresses mutant human superoxide dismutase 1 (the TgSOD1G93A mouse) also contain amyloid seeds that
accelerate the formation of new fibrils in both wildtype and mutant SOD1 protein in vitro.
Conclusions/Significance: These findings provide new insights into ALS disease mechanism and in particular a mechanism
that could account for the spread of pathology throughout the nervous system. This model of disease spread, which has
analogies to other protein misfolding disorders such as prion disease, also suggests it may be possible to design assays for
therapeutics that can inhibit fibril propagation and hence, possibly, disease progression.
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Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative
disease defined by the selective death of upper and lower motor
neurons [1,2]. Approximately 10–20% of all ALS cases are
familial (fALS), with the remainder idiopathic in origin and
defined as sporadic (sALS). Superoxide dismutase 1 (SOD1) is an
antioxidant protein expressed abundantly and ubiquitously [3]
and since the discovery in 1993 that mutations in SOD1 cause
ALS [4,5] a further 140 mutations have since been found scattered
throughout the 153 amino acid Cu/Zn-homodimer. Mutations
are mostly substitutions of single amino acid residues although
some deletions, insertions and C-terminal truncations have been
identified. SOD1 mutations are known to be causative in 10–20%
fALS cases, and have been observed in 2% sporadic cases [1].
The presence of inclusion bodies or aggresomes is one of the
neuropathological hallmarks of ALS. Spinal cord sections from
SOD1-fALS patients have been examined by immunohistochem-
istry and found to contain aggregates that are reactive to anti-
SOD1 antibodies [6]. More recent evidence has shown that in
non-SOD1 ALS (fALS and sALS), aggregates also contain SOD1
[7,8,9] and there is no marked difference in disease presentation
and progression, either clinically or neuropathologically, between
fALS and sALS [10].
ALS presents as a neurodegenerative disease beginning as a
focal weakness and atrophy of proximal limbs or body region and
progressively spreads to distal muscle groups over time [11]. Loss
of motor function appears to affect proximal motor units closest to
onset site, followed by more distal motor units and this correlates
well with the observed gradient loss of motor neurons from the
onset site [12]. Clinical disease usually starts abruptly, affecting
mostly patients in their mid-life, and has a rapid disease
progression (3–5 years) ultimately leading to death, usually due
to respiratory failure. This pattern of disease progression suggests
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some form of cell-to-cell transmission of a toxic ‘factor’, where
morbid or dying motor neurons release this toxic factor into the
extracellular microenvironment from where it is taken up by
neighbouring cells. Thus cell death may spread in a propagative
manner from the onset site. A toxic factor has not been identified,
but it has been reported that SOD1 is secreted to the extracellular
matrix [13,14] and thus secreted, misfolded forms of SOD1 could
be the toxic species responsible for the transmission of neuronal
death, if motor neurons were particularly sensitive to mutant
SOD1.
Pathogenic variants of SOD1 exert toxicity by gaining a new
biological function. A current view is that this novel function
involves an increase in the propensity of SOD1 to oligomerize with
itself or with other proteins and thereby to form some type of
aggregated species [15,16,17,18]. It is possible that different SOD1
mutants have varying tendencies to aggregate [19] and it is the
initial nucleation event of aggregation leading to formation of a
stable protein ‘seed’ that is the critical point in the misfolding
pathway – similar to that proposed for prion propagation [20,21].
The evidence of SOD1 secretion and the known phagocytic ability
of neurons [22] has led us to test the protein aggregation theory
within the prion paradigm. To do this, SOD1 fibrillization assays
with varying solvent conditions (pH and chaotrope concentration)
were undertaken and we showed in vitro that misfolding of SOD1
protein leads to the formation of amyloid fibrils which can seed the
formation of further fibrils in an autocatalytic cascade. Our results
were consistent with similar published fibrilisation experiments
[15,23,24,25,26,27] and we have gone on to demonstrate the
relevance of the seeding phenomenon to in vivo disease by seeding
fibrillization reactions with spinal cord homogenates from an ALS
transgenic mouse model (tgSOD1G93A [28]) that overexpresses a
human fALS mutant SOD1. We found the same seeding ability
with these homogenates of affected tissue as was seen with fibrils of
recombinant protein. This confirms for the first time that in an
ALS model, amyloid seeding activity is present in affected tissues.
These findings provide us with a possible disease mechanism of
ALS both in familial and sporadic disease: the spread of ALS
pathology from an initial focal point can be accounted for by the
seeding of amyloid fibrils in a transmissible process analogous to
that of prion propagation. Therefore inhibition of SOD1
fibrillisation protentially provides a point for therapeutic interven-
tion that could halt the progression of disease.
Results
SOD1 fibrillization can be potentiated over a wide range
of destabilizing conditions
Prior to characterizing the fibrillization properties of SOD1, all
protein preparations were characterized biophysically and bio-
chemically (Supporting Information S1, Figures S1, S2, S3, S4 and
Tables S1 and S2) to ensure the SOD1 proteins used in
subsequent assays were comparably metallated and had an intact
intra-disulfide bond, when validated against other published
reports. To screen and select for a condition which would be
conducive for SOD1 to form oligomers and amyloid-like fibrils,
human SOD1 proteins – wildtype SOD1 (wtSOD1) and four
fALS causative mutations, G93A, G37R, A4V, and G85R, were
incubated in a matrix of 28 varying solvent conditions (pH and
chaotrope/denaturant concentration), totalling 140 screened
conditions for all five proteins studied. We monitored fibril
formation by following the change in Thioflavin-T (ThT)
fluorescence. Figure 1 shows the conditions screened (a gradient
of guanidium chloride (GdnHCl) concentration from 0.0 to 3.0M
at pH4.0 or 5.0) which gave a positive change in ThT during the
assay, represented by color-coded squares for each SOD1 variant.
A positive change in ThT was indicative of fibril formation, which
was further confirmed by electron microscopy. All SOD1 variants
were able to form fibrils in at least one combination of pH – either
at pH4.0 and/or 5.0 but not at pH 7.5 or 9.0 – and GdnHCl
concentration. Fibril formation was more favourable at pH4.0 in
mild denaturing conditions (low GdnHCl concentration) and at
pH5.0 in slightly harsher denaturing conditions (higher GdnHCl
concentration).
Kinetics of spontaneous and seeded fibrillization of SOD1
Spontaneous and seeded reactions were set up to characterise
the lag time of fibril formation and additionally for seeded
reactions to investigate if addition of preformed SOD1 amyloid
fibrils altered the rate of further fibril formation (‘self seeding’, ‘ss’)
in an autocatalytic cascade. With the exception of G85R,
fibrillization of all SOD1 proteins was carried out at pH4.0 with
0.5M GdnHCl. Fibrillization of G85R was carried out at pH5.0
with no denaturant. The fibrillization lag times of each SOD1
variant were determined for each type of reaction. Figure 2 shows
the data fitted fibrillization curve of spontaneous and self-seeded
reactions, these values are summarised in Table 1.
A comparison of the rate of spontaneous fibrillization showed
the lag time for wtSOD1 fibrillization (206 hrs) was considerably
longer than for the other SOD1 mutants (mean 6 standard
deviation = 131627 hrs). However, in the self-seeded reactions of
wtSOD1 the lag time of fibrillization was reduced to 16 hrs, which
is consistent with the lag times of self-seeded SOD1 mutants except
for G85R (25611 hrs). The lag time of G85R was excluded from
this range because G85R was fibrillized under different conditions
compared to other SOD1 variants. Figure 2 shows that while
Figure 1. Conditions screened for SOD1 fibrillisation. SOD1
variants with higher stability were able to form fibrils over a wide range
of conditions (i.e. number of combinations of pH and denaturant
strength) characterized by variation in lag times (wtSOD red square = 10
combinations; G93A light blue square= 6 combinations; G37R green
square = 5 combinations; A4V dark blue square= 2 combinations; G85R
yellow square = 2 combinations). For the more stable proteins, when
incubated in increasing denaturant strength, lag time for fibrils to form
is shortened (data not shown).
doi:10.1371/journal.pone.0010627.g001
SOD1 Seeds Fibrillisation
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spontaneous reactions (solid circles) had relatively long incubation
events, self-seeded reactions (solid triangles) for all SOD1 variants
(except G85R) displayed significantly reduced lag times, with an
average reduction of 82% (unpaired student t-test, p-value,0.001,
when compared to lag times of spontaneous reactions). These
findings confirm the generic property of SOD1: both wtSOD1 and
Figure 2. Spontaneous and self-seeded fibrillization of SOD1. Spontaneous and self-seeded reactions for (A) wtSOD1, (B) G93A, (C) G37R, (D)
A4V, and (E) G85R. All SOD1 variants, except G85R were incubated at 37uC, at pH4.0 in mild denaturing condition (0.5M GdnHCl). Fibrillization of G85R
was performed at pH5.0 with no denaturant. Fibril formation is reported as % maximum ThT relative fluorescence units (RFU) shown as a function of
time (hrs). Seeded reactions were spiked with 1% preformed fibrils (v/v). Data shown are average values from 6–10 replicates (6 SEM) pooled from 2–
3 independent assays. Seeded fibrillization reactions consistently shortened the lag times by an average of 82% (except for G85R) compared to
spontaneous reactions under similar conditions.
doi:10.1371/journal.pone.0010627.g002
SOD1 Seeds Fibrillisation
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mutant SOD1 form fibrils; once formed, these fibrils have the
ability to propagate fibrillization in an autocatalytic manner.
To investigate if pre-formed fibrils of SOD1 mutants were able
to initiate fibrillization of wtSOD1 and reduce the lag time of fibril
formation, cross-seeded (‘cs’) reactions were performed for all
SOD1 mutants in a similar manner as the self-seeded reactions. All
fibrillization reactions were carried out at pH4.0 in the presence of
0.5M GdnHCl. We found reactions cross-seeded with pre-formed
fibrils of all SOD1 mutants (except G85R) shortened the lag time
of wtSOD1 fibrillization by an average of 83% (from 206 hrs
down to 3563 hrs depending upon the mutation), as shown in
Figure 3 and summarised in Table 2.
Testing spinal cord homogenates to determine the in vivo
relevance of SOD1 fibrillization. As shown in Figures 2 and 3,
SOD1 has a generic property of forming, and seeding formation of,
amyloidogenic structures in vitro. To start to investigate the in vivo
relevance of these results, fibrillization assays were undertaken with
tissue homogenates from spinal cord of mice, seeded into wtSOD1
and G93A protein preparations. Spinal cord homogenates were
taken from three different mouse strains: (1) tgSOD1G93A transgenic
mice carrying the pathogenic SOD1 G93A mutation; (2)
tgSOD1wtSOD1 transgenic mice overexpressing wildtype human
SOD1 at a similar level to the tgSOD1G93A mice; these mice do not
succumb to motor neuron disease; (3) wildtype control non-
transgenic littermates from the tgSOD1G93A colony. Spinal cords
were obtained from animals at 120 days old, corresponding to the
clinical end-stage age of tgSOD1G93A mice on the genetic
background used.
Results from these spinal cord homogenate-seeded reactions are
shown in Figure 4 and the lag times are summarised in Table 2. In
seeding reactions of wtSOD1 and G93A mutant proteins by
tgSOD1G93A spinal cord homogenates, fibrillization was initiated
at 56 hrs and 23 hrs respectively. This is comparable to the lag
times of self-seeded recombinant G93A protein (33 hrs) and cross-
seeded recombinant G93A into wtSOD1 protein (33 hrs). Seeded
reactions with tgSOD1wtSOD1 and non-transgenic control spinal
cord homogenates into G93A protein gave lag times of
approximately 81 hrs and 86 hrs respectively. Although these
numbers appear to be shorter than the lag times for spontaneous
reactions (156639 hrs; G85R data excluded), the difference was
determined to be statistically insignificant, using an unpaired
student t-test giving a p-value of 0.07. As expected, there was no
significant ThT fluorescence change when non-transgenic control
spinal cord homogenates were used to seed wtSOD1 protein,
indicating no fibrillization. However, we note that SOD1
aggregates have been reported in older wtSOD1 transgenic mice
(,600days) [29], and it would be interesting, for future
experiments, to investigate if these aggregates found in older mice
have any seeding ability also.
To test for the specificity of the seeding effects found with spinal
cord homogenates from end stage tgSOD1G93A mice, spinal cord
homogenates of non-ALS related mouse models and brain
homogenate from a human neurodegenerative disease were
assayed. Spinal cord homogenates from Tg20 mice infected with
the RML strain of prions [30], huntingtin transgenic mice (N171-
82Q) [31], and human brain homogenate from frozen post
mortem material of a patient who died with frontotemporal
dementia from a CHMP2B mutation (FTD3 [32]) were used as
seeds in the same in vitro fibrillization assay. These controls showed
no significant ThT fluorescence change when seeded into
wtSOD1 or G93A proteins (Figure 4). Thus the significantly
shortened seeding lag time found with tissue homogenates from
Table 1. Summary of lag times of SOD1 fibrillization for spontaneous and seeded reactions.
SOD1 variant Fmax (a.u.) T0.5 (hrs) t (hrs) Lag time spontaneous Fmax (a.u.) T0.5 (hrs) t (hrs) Lag time self-seeded
wt SOD1 2061863517 223.060.9 8.760.7 205.760.5 17073612201 24.860.8 4.460.6 16.060.6
G93A 19041612443 158.460.4 9.660.3 139.260.3 21964615221 43.260.3 5.060.2 33.160.2
G37R 41649623461 136.560.7 10.760.6 115.060.4 34286612334 46.760.5 4.960.5 37.060.4
A4V 51191614760 217.960.5 26.260.4 165.360.4 908065952 22.761.0 3.161.0 16.661.0
G85R 650762199 128.060.5 11.860.4 104.060.3 699262205 118.460.8 16.760.7 85.160.5
Fmax = average maximum fluorescence (arbitrary unit, a.u.), T0.5 = observed time at transition mid-point (hrs), lag time = incubation duration prior to increase in
fluorescence corresponding to initiation of fibrillization (hrs), t= 1/propagation rate of fibril growth (hrs). Data shown are average values from 6–10 replicates (6 SEM)
pooled from 2–3 independent assays.
doi:10.1371/journal.pone.0010627.t001
Figure 3. Cross-seeding (cs) fibrillization reactions with pre-
formed fibrils of SOD1 variants into wtSOD1. Formation of fibrils
are reported as % maximum ThT relative fluorescence units (RFU)
shown as a function of time. Seeded reactions were spiked with 1%
preformed fibrils (v/v). Data shown are average values from 6–10
replicates (6 SEM) pooled from 2–3 independent assays. Self-seeding of
wtSOD1 fibrils into recombinant wtSOD1 (wtSOD1 ss) gave the greatest
reduction in lag time with cross-seeding of G93A, G37R, and A4V into
wtSOD1 shortening the lag time from 206 hours to between 33 and
38 hours (lag time shortened by approximately 83%). G85R was also
capable of reducing the lag time for wtSOD1 fibrillisation but less
significantly (33% reduction in lag time).
doi:10.1371/journal.pone.0010627.g003
SOD1 Seeds Fibrillisation
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tgSOD1G93A mice is not simply associated with a generic process
of neurodegenerative disease but rather due to the presence of a
specific species of SOD1, found in the spinal cord of tgSOD1G93A,
which has similar seeding properties to recombinant SOD1 fibrils
formed in vitro.
Qualitative characterization of ThT-positive SOD1 species
by electron microscopy
ThT-positive SOD1 samples were examined by electron
microscopy (EM) to determine if we could detect species with a
fibrillar, amyloid-like morphology. Random ThT-positive SOD1
samples were selected for qualitative EM characterization. Higher
order structures resembling amyloid were observed for all samples
analysed, which confirmed the change in fluorescence during
fibrillization reactions was indeed due to formation of fibrils.
These amyloid structures varied in length, Figure 5, from shorter
fragments (yellow arrows) to longer thread-like fibrils (green
arrows) and in thickness from a thin wiggly appearance (black
arrows) to thicker fibrils with 2–3 intertwined protofilaments (red
arrows). Occasionally, a less structured morphology was also
observed in some ThT-positive SOD1 samples. In Figure 5(E),
G85R ThT-positive species mostly appeared as spherical aggre-
gates and some possessed a doughnut-like appearance. The
significance of the difference in morphologies is unknown, but
the common property observed in all ThT-positive SOD1 samples
was the increase in the propensity of the most structurally altered
SOD1 mutants to aggregate, apparently independently of the
adopted morphology of the ThT-positive species.
Destabilization of SOD1 is a predisposing property of
fibrillization
By plotting temperature values for the half-point of thermal
denaturation (Tm) (Supporting Information S1) against the
fibrillization propagation rates and lag times of all SOD1 variants
for both spontaneous and seeded reactions (Figure 6), the
fibrillization propensity of SOD1 can be correlated with protein
stability. In spontaneous fibrillization reactions, SOD1 variants
with lower protein stability (reflected by lower Tm values) had a
higher propensity to form fibrils quickly (shorter lag time; Figure 6).
However, in seeded reactions, there was no appreciable correla-
tion of protein stability to lag time although there was a trend that
higher stability may promote seeded fibrillization. This is in line
with the aggregation theory proposed by others where destabili-
zation of SOD1 promotes formation of aggregates, which are
detrimental to motor neurons [33,34,35,36,37,38,39]. Here, it is
demonstrated that formation of fibrils is an alternative misfolding
property of destabilized SOD1 resulting in higher order structures
with the intrinsic ability to autocatalyze the formation of more
fibrils as opposed to the formation of poorly-defined or
unstructured aggregates.
Discussion
The altered biological function that results in mutant SOD1
toxicity and leads to ALS pathology remains obscure. Here, we
demonstrate the ability to form self-propagating amyloid structures
is a common property of wildtype, G93A, G37R, A4V, and G85R
SOD1, and that cross-seeding of pre-formed mutant fibrils, or
spinal cord homogenate for tgSOD1G93A animals into wildtype
SOD1 can also induce conformational change in wtSOD1 to form
amyloid. This property, possibly toxic under certain abnormal
cellular microenvironments, is potentially how SOD1 may be led
into a propagating misfolding pathway that results in cell death
and clinical pathology.
In contrast to earlier reports where SOD1 was used in the
demetallated and disulfide reduced state [15,23,24,25,26,27], we
used the intact and active SOD1 as the starting material in our
fibrillization assay (Supporting Information S1).
Both wildtype SOD1 and its mutant variants were able to
fibrillize in a variety of conditions and in common with other
amyloidogenic proteins, we found that SOD1 variants were able
to form fibrils more readily at low pH. This is consistent with
previous reports [25,40,41] demonstrating the ability of deme-
tallated and reduced forms of SOD1 to form amyloid between
pH3.0 and 5.0 with the addition of 0–2M GdnHCl. The
similarities of our results with those of others suggest the
fibrillizing property of SOD1 does not depend upon aberrant
Table 2. Summary of lag times of SOD1 fibrillization for seeded reactions with pre-formed fibrils of SOD1 mutants into wtSOD1
protein and with spinal cord homogenates into G93A and wtSOD1 proteins.
Fibrillisation reaction Fmax (a.u.) T0.5 (hrs) t (hrs) Lag time (hrs)
Cross-seeded (CS) reactions with pre-formed SOD1 mutant fibril (Figure 2)
G93A cs wtSOD1 2221469547 54.660.6 10.960.4 32.860.3
G37R cs wtSOD1 648265934 54.662.4 8.562.2 37.662.0
A4V cs wtSOD1 982864252 49.762.0 8.361.8 33.261.7
G85R cs wtSOD1 26714611056 172.961.0 18.160.7 136.760.5
Seeded reactions with spinal cord homogenates (Figure 4)
Spinal cord tgSOD1G93A seeded into wtSOD1 protein 21406690 78.060.5 11.060.4 56.060.3
Spinal cord non- transgenic control seeded into wtSOD1 protein 13526114 n/a n/a n/a
Spinal cord tgSOD1wtSOD1 seeded into wtSOD1 protein 16216210 n/a n/a n/a
Spinal cord tgSOD1G93A seeded into G93A protein 746964148 34.360.8 5.860.5 22.660.3
Spinal cord non- transgenic control seeded into G93A protein 27026444 111.161.9 15.061.4 81.160.9
Spinal cord tgSOD1wtSOD1 seeded into G93A protein 20776366 115.662.5 14.862.1 86.061.7
Fmax = average maximum fluorescence (arbitrary unit, a.u.), T0.5 = observed time at transition mid-point (hrs), lag time = incubation duration prior to initiation of
fibrillization (hrs), t= 1/propagation rate of fibril growth (hrs), tgSOD1G93A = transgenic SOD1 mice carrying the G93A mutation, tgSOD1wtSOD1 = transgenic wtSOD1
overexpressor mice; n/a = not available. Data shown are average values from 4 to 10 replicates (6 SEM) pooled from 2 to 3 independent assays.
doi:10.1371/journal.pone.0010627.t002
SOD1 Seeds Fibrillisation
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protein modifications, which may occur during protein produc-
tion and purification.
The spectrum of guanidinium-induced destabilizing conditions
at a fixed pH suggests that fibril formation is a conformation-
dependent process, with some limited degree of unfolding and
destabilization required without complete denaturation to a
random coil state in order to expose the critical interaction
domains required for oligomerization. SOD1 variants with higher
stability were able to form fibrils over a broad range of
fibrillization conditions but with a predictable trend whereby
denaturing activity was inversely proportional to lag time for fibril
formation, This was consistent with the work of Oztug-Durer and
colleagues [41] who showed the lag time for fibril formation was
shortened with increasing GdnHCl concentration.
This could also explain why G85R, which is markedly
destabilised compared to the wildtype protein (Figure S1,
Spectroscopic characterisation by far and near UV circular
dichroism), failed to form fibrils at pH4, 0.5M GdnHCl, in the
presence of any denaturant. It is likely that in the presence of
GdnHCl, G85R may undergo excessive unfolding, thus losing the
capacity to adopt the correct misfolded conformation needed for
oligomerization. Even at pH5.0, G85R is already significantly
destabilised which reduces the likelihood of G85R favourably
adopting or misfolding to the correct propagating conformation,
thus, rendering G85R less responsive, in comparison to other
more stable SOD1 variants, to the presence of a template in
promoting fibrillar growth.
Seeded reactions clearly demonstrate that SOD1 fibrils possess the
ability to seed the formation of further fibrils in an autocatalytic
manner and significantly reducing the lag time of fibrillization (in
both self-seeded and cross-seeded reactions). Remarkably, a similar
seeding effect was observed using tissue homogenates from
tgSOD1G93Amice (but not from tgSOD1wtSOD1), which was capable
of stimulating the fibrillization of both wildtype and mutant protein.
At first glance, by comparing lag times in seeded reactions, it may
appear as if non-transgenic wildtype and tgSOD1wtSOD1 spinal cord
extracts have seeding activities. However, analysis showed that
although the lag times (for G93A seeding reactions using these
extracts) appear to be smaller than lag times for recombinant proteins
subjected to spontaneous fibrilization reactions under identical
fibrillizing condition (i.e. pH4, GdnHCl 0.5M), the difference is
statistically insignificant (p = 0.07, calculated using unpaired student
t-test). Thus although these extracts may give rise to an apparent
slightly shorter lag time, they do not possess a statistically significant
seeding activity, thus further supporting our proposal that a specific
conformer in the spinal cord extracts of tgSOD1G93A (likely mutant
SOD1, in misfolded form/s) may be responsible for the seeding
effects observed in the seeding assays. The absence of any seeding
activity in tissue homogenates derived from tgSOD1wtSOD1 mice adds
further credence to the hypothesis that seeding activity is related to
ALS pathology as tgSOD1wtSOD1 mice do not develop any detectable
clinical phenotype, explicable by an absence of amyloid and
amyloidogenic seeds within this paradigm.
Potentially, the formation of amyloid fibrils in vivo can be
induced when the cellular microenviroment is unhealthy and
damaging, for example, in conditions of increased oxidative stress.
Since tgSOD1wtSOD1 mice do not succumb to motor neuron
disease, it is likely that the in vivo conditions are physiologically
healthy, and so the cellular microenviroment is not sufficient to
promote the formation of wtSOD1 fibrils in these mice. This is
further supported by the other tissue seeding controls used (spinal
cord from non-transgenic wildtype littermates, Tg20 mice infected
with RML strain of prions, huntingtin transgenic mice, and brain
homogenate from an FTD3 patient) in which no seeding effect was
observed. Tg20(RML) and huntingtin mice are amyloidogenic
models of prion and huntingtin diease, and both mouse strains
have been shown to form amyloidogenic proteins in the brain
[42,43,44]. Here, the absence of a seeding effect when using
homogenates from these mouse strains indicates that the SOD1
fibrilisation mechanism is a protein specific process. This is
consistent with the active ‘seed’ in the tgSOD1wtSOD1 spinal cord
homogenate being a conformer of SOD1.
A limitation of this study lies in the definitive identification of
SOD1 fibrils as the propagative-SOD1 conformer or ‘template’ in
these homogenates responsible for the seeding effects. Although we
Figure 4. Fibrillogenic seeding with affected tissue homoge-
nates. wtSOD1 (top graph) and G93A (bottom graph) proteins were
seeded with spinal cord homogenates from 120 days old tgSOD1G93A
(red triangle), tgSOD1wtSOD1 (light blue triangle) and control non-
transgenic littermates of the tgSOD1G93A (green triangle) mice. Seeded
reactions spiked with 1% (v/v) tgSOD1G93A spinal cord homogenates
into wt SOD1 and G93A proteins shortened the lag times to
approximately 56 hrs and 23hrs respectively, comparable to seeded
reactions with pre-formed recombinant G93A fibrils to wt SOD1 and to
self-protein (G93A) (refer to Table 1). The lag times of seeded reactions
with tgSOD1wtSOD1 and non-transgenic control spinal cord homoge-
nates into G93A protein were 1.5–3.5 fold longer than the lag times of
seeded reactions by tgSOD1G93A spinal cord homogenates into G93A
protein. Seeding with tgSOD1wtSOD1 and non-transgenic control spinal
cord homogenates into wtSOD1 protein did not give rise to any ThT
fluorescence change, indicating an absence of fibril formation.
Additional spinal cord homogenate controls were used to test for
seeding specificity as described in the text: spinal cord homogenates
were prepared from clinical endstage Tg20 mice infected with the RML
strain of prions (dark blue triangle), huntingtin transgenic mice (N171-
82Q) (grey triangle), and brain homogenate prepared derived from an
FTD3 patient (yellow triangle).Data shown are average values from 4–10
replicates (6 SEM) pooled from 2–3 independent assays.
doi:10.1371/journal.pone.0010627.g004
SOD1 Seeds Fibrillisation
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did not demonstrate the presence of SOD1 fibrils in the spinal
cord homogenates we used, others have shown that amyloid fibrils
and Thioflavin-reactive inclusions are present in the spinal cord of
tgSOD1G93A mice and mouse models expressing G37R and G85R
[45]. Additionally, histopathological analysis of spinal cord
sections demonstrated via electron microscopy, that these fibrillar
structures were immunopositive for human SOD1 [46,47]. Thus
given these results on the presence of SOD1-positive fibrillar
aggregates in the spinal cord of SOD1-ALS mouse models, it is
reasonable to speculate that the ‘seed’ responsible for seeding may
Figure 5. Representative electron micrographs of SOD1 fibrils from spontaneous and seeded reactions (self-seeded and cross-
seeded with pre-formed fibril/oligomer or with spinal cord tissue homogenate). Samples from fibrillization reactions of (A) A4V
spontaneous, (B) A4V self-seeded, (C) A4V cross-seeded samples into wtSOD1 protein, (D) G37R spontaneous, (E) G85R spontaneous, (F) G85R self-
seeded, (G) G93A spontaneous, (H–I) tgSOD1G93A spinal cord homogenate seeded into G93A protein. All spontaneous, self- and cross-seeded
reactions for all SOD1 variants were carried out at pH4.0 with 0.5M GdnHCl, except for G85R which was carried out at pH5.0 without any denaturant.
Shorter fibrillar fragments are indicated by yellow arrows, which were observed in all samples. Green arrows point to longer and continuous fibrillar
threads, whereas black arrows indicate thinner and less regular SOD1 species (possibly shorter oligomers). Blue arrows in (E) point to a less structured
morphology of G85R ThT-positive species (most appear as spherical aggregates but some have a toroidal appearance) a morphology which was also
rarely observed in other SOD1 fibrillar samples. Red arrows in (H) and (I) indicate flexion points of what appears to be 2–3 protofilaments together to
form a thicker fibrillar thread or fragment. All SOD1 fibril samples which were qualitatively characterized under EM showed a common property of
increased propensity to clump together or to aggregate, regardless of the morphology of the ThT-positive species. Scale bar = 400nm.
doi:10.1371/journal.pone.0010627.g005
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be SOD1 pre-fibrillar aggregates present in the sample or
produced from partial dissociation of the monomers from fibrils
[48]. However, we note that it remains a possibility that diseased
spinal cord contains other factors that may have some effect on
seeding. If this is true, this could explain why the kinetics of
fibrillization using homogenates versus purely recombinant ‘seed’ is
slightly different, although not statistically significant.
The present findings parallel clinical observations of disease
progression in humans and in mouse models. Classical human
ALS cases display a long latent pre-clinical phase with disease
onset in mid-life, and usually a rapid disease progression with
death occurring within 2–5 years; a phenotype mirrored in ALS
mouse models. The late onset of disease is analogous to the long
lag time observed in spontaneous fibrillization reactions suggesting
nucleation and the establishment of fibril seeds is the rate-limiting
step in pathogenesis. Furthermore, the aggression of the disease
upon onset is consistent with the in vitro fibrillization profile, where
by once fibrils are formed further recruitment and oligomerization
of SOD1 is a rapid process limited only by substrate concentra-
tion. The cell type specificity of this disorder remains a mystery,
but may be associated with a sensitivity of these cells to SOD1
aggregates, and perhaps to the phagocytic capacity of motor
neurons which promotes uptake of mutant SOD1 proteins [22].
Given the ability of SOD1 to be secreted from cells
[13,49,50,14,51], non-cell autonomous toxicity of mutant SOD1
[52,53,54], the acquisition of mutant properties by wtSOD1 when
oxidized or misfolded [55] and the clinical observation of disease
focality, spread of paralysis and the gradient of motor neuron loss
in the spinal cord from onset site [11,12], we propose a mechanism
of disease pathogenesis arising from the generic property of SOD1
to form amyloid. We suggest that in certain cellular and possibly
also extra cellular conditions, the highly abundant protein SOD1
can form stable amyloid fibrils associated with self-propagating
amyloidogenic seeds. Amyloid fibril formation is promoted
significantly by mutations, but is also a property of the wildtype
SOD1 protein. The amyloidogenic nuclei of SOD1 may be
transferred from one cell to another in a propagative manner in
line with the non-cell autonomous theory involving motor
neurons, microglia and astrocytes. We hypothesize that toxic
SOD1 conformers are formed as part of this replication process
analogous to the proposed formation of toxic species in other
protein misfolding disorders such as prion disease [20,21] and
tauopathies [56].
We propose that in many ways SOD1 follows a ‘‘prion-like’’
mechanism by seeding the transformation of native SOD1 into
fibrillar species which may transmit this transforming ability from
cell to cell. Fibrillar or pre-fibrillar species are presumed to be toxic
the spread of which would result in a progressive loss of cells from
the site of onset. We have chosen to use the term ‘‘prion-like’’
because of the nucleation dependent polymerization property of
SOD1, as observed in the seeding experiments. This seeding effect
was not confined to seeding into an identical primary sequence, but
can also cross-seed between minor mismatches in sequence from
mutant to wild-type proteins sharing some analogy to human prion
disease. Although our data is limited to the propagation of altered
protein confromation and we have not explored the potential
cytotoxicity of fibrillar and pre-fibrillar SOD1 these could be the
transmissible factors resulting in spread of motor neuron cell death.
The impact of this proposed mechanism is exciting because it
points towards the possibility of a practical approach to the
treatment of ALS, both familial and sporadic cases. Slowing down
or even halting disease progression after onset could be achieved
by identifying compounds that inhibit amyloid formation either by
stabilizing the native conformation of SOD1 or by directly
inhibiting the fibrillization process, as proposed in prion disease
[57]. Indeed suggestions from other neurodegenerative diseases
indicate that minor reductions in the propagation rates of toxic
assemblies can allow normal cellular clearance mechanism to
degrade amyloidogenic nuclei thereby providing a potential
treatment and perhaps ultimately a cure.
Materials and Methods
Ethics statement
All work involving mice was carried out under Licence from and
in accordance with UK Home Office requirements. This study
was approved by the local ethical review panel (ERP) of the MRC
Prion Unit.
Expression, purification and characterization of human
SOD1 variants
SOD1 proteins, wildtype and four mutants (G93A, G37R, A4V
and G85R), were produced in and purified from an E.coli expression
system. All expression constructs were based on the cSOD1 plasmid
[58], which had been modified as described and subcloned into the
pET28 expression vector (Novagen) [59]. Each protein preparation
was subjected to characterization of their functional activity using a
commercial assay kit (Oxis), secondary and tertiary structure
assessment using circular dichroism (CD), protein thermo-stability
evaluation using differential scanning fluorimetry (DSF) and SOD1
dimerization status determination using analytical ultracentrifuga-
tion (AUC) (see Supporting Information S1).
Preparation of tissue homogenates
Spinal cord obtained from sacrificed mice were homogenised as
a 10% w/v preparation in Dulbecco’s phosphate-buffered saline
(PBS) lacking Ca2+ and Mg2+ (Sigma) using a Duall tissue grinder
(Anachem).
Figure 6. The effect of protein stability on the lag time of SOD1
fibrillization for spontaneous and self-seeded reactions. The plot
shows the correlation of SOD1 stability, in the metallated and intra-subunit
intact form, (expressed as melting temperature, Tm (uC)) to lag time (hrs).
Destabilisation of SOD1 correlated with shorter lag times for fibrillisation in
spontaneous reactions, whereas reactions initiated with pre-formed fibrils
had lag times that were independent of the original native fold stability.
(Tm data for G85R not available, thus it was not possible to include the
G85R fibrillization lag time and propagation rate in the graphs.)
doi:10.1371/journal.pone.0010627.g006
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In vitro conversion of SOD1 into amyloid fibrils
To form amyloid fibrils a stock solution of SOD1 protein,
wildtype and mutants (G93A, G37R, A4V, G85R) (1.3–1.5 mg/
ml) was diluted to a final protein concentration of 10mM in 20mM
Tris-acetate buffer, with varying concentrations of guanidium
hydrochloride (GdnHCl) and at varying pH (4.0, 5.0, 7.5 and/or
9.0), containing a final concentration of 10mM Thioflavin-T
(ThT). Four Hybaid Ribolyser beads were placed into each well of
a 96-well transparent flat-bottom plate; then 200ml reaction
mixture containing diluted protein and ThT was pipetted into
wells, and the plates were covered using an optically corrected
adhesive film. The plates were incubated at 37uC with continuous
shaking at 830 rpm using a plate incubator shaker (GrantBio). The
kinetics of fibril formation were monitored by taking time point
measurements of fluorescence emission at 485nm when excited at
450nm using a fluorimeter plate reader (Spectrofluor, Tecan). For
seeded reactions, 2ml of preformed fibrils from a previous
spontaneous reaction or 10% w/v tissue homogenate were added
to 200ml reaction as described above.
The lag phase of amyloid formation was determined by fitting
the time-dependent changes in the fluorescence of ThT (F)
overtime of the reaction (t) to the following equation:
F~AzB= 1zexp k  tm{tð Þ½ ð Þ
where A is the base level of ThT fluorescence during the lag phase, B
is the difference between final level of ThT fluorescence at plateau
and the initial level during the lag phase, k is the rate constant of
fibril growth (h21), and tm is the observed time at midpoint of
transition. The lag time (tl) of fibril formation was calculated as:
tl = tm22/k as previously described by Nielsen et al [60].
Characterization of ThT-positive species by electron
microscopy
For negative stain EM, 3.5ml fibril preparation was applied to a
carbon-coated, glow-discharged, 300-mesh copper grid and
blotted after 2–3 min. The grids were stained with 3.5ml 2% (w/
v) uranyl acetate, blotted after 3 min and allowed to air-dry.
Images were recorded using minimal electron dose at a
magnification of 27,0006 in a Tecnai T10 microscope (FEI,
Eindhoven, NL) with a tungsten filament operating at 100 kV.
The defocus for these images ranged between 300 nm and
1000 nm, allowing the inclusion of data to a spatial frequency of
(20A˚21) without CTF correction.
Supporting Information
Supporting information S1 Supporting information: Results
and Discussion, Materials and Methods, References.
Found at: doi:10.1371/journal.pone.0010627.s001 (0.11 MB
DOC)
Figure S1 Spectroscopic characterisation by far and near UV
circular dichroism (CD). All proteins displayed spectra which were
similar to wtSOD1 with the exception of G85R. Deviation of far-UV
CD spectra for G85R from wtSOD1 reflects some degree of loss of
secondary structure, but little change in near-UV spectra (inset)
reflecting no significant perturbation of aromatic residue environments.
Found at: doi:10.1371/journal.pone.0010627.s002 (0.65 MB TIF)
Figure S2 Coomassie Blue stained SDS-PAGE showing the
purity of recombinant SOD1 proteins. Positions of molecular
weight markers are indicated in kiloDaltons.
Found at: doi:10.1371/journal.pone.0010627.s003 (0.58 MB TIF)
Figure S3 SOD1 assembly state as determined by analytical
ultracentrifugation (AUC). Sedimentation velocity (SV) profile of
SOD1 proteins (at three concentrations) based on the continuous
size-distribution (c(S)) model. The analysis included all 200 scans
acquired during the experimental runs, which were analysed using
the Sedfit software (version 9.2) based on the continuous size
distribution model. The larger the s-values, the larger the size of
the sedimenting protein species. SOD1 dimers and monomers
sedimented between 2.8 and 3.1S and 1.4 and 1.8S, respectively.
All proteins except A4V, and G85R existed almost exclusively as
SOD1 dimers. A4V and G85R showed a higher propensity to
monomerize. G85R had multiple peaks with s-values larger than s-
values for dimeric SOD1, indicating that the destabilised G85R
has a high propensity to aggregate.
Found at: doi:10.1371/journal.pone.0010627.s004 (1.02 MB TIF)
Figure S4 SOD1 thermo-stability as determined using differen-
tial scanning fluorimetry (DSF). Protein unfolding was monitored
by slow thermal unfolding using the SYPRO Orange reporter dye
over a temperature range of 40 to 95uC for: (A) wtSOD1, (B)
G93A, (C) G37R, (D) A4V. Protein stability was dependent on
both concentration (11uM vs. 33uM) and degree of metallation.
Proteins were most stable at higher concentrations, and when
metallated. Demetallation with EDTA markedly reduced protein
stability at all concentrations analysed by approximately 20uC. It
was not possible to plot a thermal denaturation profile for G85R
using DSF as G85R was relatively unfolded to begin with, thus
giving very high initial fluorescence which makes data plot invalid
as no co-operative unfolding transition could be observed.
Found at: doi:10.1371/journal.pone.0010627.s005 (0.94 MB TIF)
Table S1 Functional activity of SOD1 variants.
Found at: doi:10.1371/journal.pone.0010627.s006 (0.01 MB
DOCX)
Table S2 Summary of SOD1 stability profiles.
Found at: doi:10.1371/journal.pone.0010627.s007 (0.01 MB
DOCX)
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